Caribou Biosciences (CRBU) Non-Current Assets (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Non-Current Assets data on file, last reported at $26.6 million in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 52.75% year-over-year to $26.6 million in Q1 2026; TTM through Mar 2026 was $124.6 million, a 65.31% decrease from a year earlier, with the FY2025 full-year figure at $30.1 million, down 67.92% from the prior year.
• Non-Current Assets for Q1 2026 stood at $26.6 million, down from $30.1 million in the prior quarter.
• Over the last five years, Non-Current Assets for CRBU reached as high as $113.5 million in Q4 2022 and fell as low as $26.6 million in Q1 2026.
• Historically, Non-Current Assets has averaged $78.1 million across 5 years, with a median of $91.9 million in 2022.
• Across the five-year window, Non-Current Assets surged 611.69% in 2022 and plunged 72.18% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $113.5 million in 2022, then slipped by 17.75% to $93.4 million in 2023, then advanced by 0.61% to $93.9 million in 2024, then slumped by 67.92% to $30.1 million in 2025, then decreased by 11.67% to $26.6 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $26.6 million in Q1 2026, $30.1 million in Q4 2025, and $39.5 million in Q3 2025.